View in EDS

Interleukin-6 levels decrease following rituximab treatment but increase following tocilizumab treatment.

Saved in:
Bibliographic Details
Title: Interleukin-6 levels decrease following rituximab treatment but increase following tocilizumab treatment.
Authors: Ide M; Department of Hematology, Takamatsu Red Cross Hospital, 4-1-3 Ban-cho, Takamatsu, 760-0017, Kagawa, Japan. makoto13@smile.ocn.ne.jp.; Kagawa Red Cross Blood Center, Takamatsu, Kagawa, Japan. makoto13@smile.ocn.ne.jp., Fukumoto T; Department of Hematology, Takamatsu Red Cross Hospital, 4-1-3 Ban-cho, Takamatsu, 760-0017, Kagawa, Japan., Ohnishi H; Department of Hematology, Takamatsu Red Cross Hospital, 4-1-3 Ban-cho, Takamatsu, 760-0017, Kagawa, Japan., Okamura S; Department of Hematology, Takamatsu Red Cross Hospital, 4-1-3 Ban-cho, Takamatsu, 760-0017, Kagawa, Japan., Kawano K; Department of Hematology, Takamatsu Red Cross Hospital, 4-1-3 Ban-cho, Takamatsu, 760-0017, Kagawa, Japan., Yokoyama T; Department of Nephrology, Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan., Kameda T; Department of Rheumatology, Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan.
Source: Annals of hematology [Ann Hematol] 2026 Jun 13. Date of Electronic Publication: 2026 Jun 13.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0584
DOI:10.1007/s00277-026-07130-w